1 Monster Stock in the Making to Buy and Hold
Summit Therapeutics (US:SMMT) The Motley Foolยท2025-10-05 13:45This biotech company was relatively unknown a few years ago.Even in hindsight, it would have been difficult to predict Summit Therapeutics' (SMMT 2.88%) exceptional rise over the past three years. The company's shares have skyrocketed by more than 1,500% over this period. That's impressive even by the standards of the volatile biotech industry. Now looking forward, great things seem to be awaiting the biotech.Let's discuss why Summit Therapeutics is still worth investing in today.The "Keytruda killer"Why ha ...